Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA384119
Max Phase: Preclinical
Molecular Formula: C72H84Cl3N27O12
Molecular Weight: 1516.62
Molecule Type: Small molecule
Associated Items:
ID: ALA384119
Max Phase: Preclinical
Molecular Formula: C72H84Cl3N27O12
Molecular Weight: 1516.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.Cl.Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4cc(C(=O)Nc5cc(C(=O)Nc6cc(C(=O)Nc7cc(C(=O)NCCC(=N)N)n(C)c7)n(C)c6)n(C)c5)cc(C(=O)Nc5cc(C(=O)Nc6cc(C(=O)Nc7cc(C(=O)NCCC(=N)N)n(C)c7)n(C)c6)n(C)c5)c4)cn3C)cn2C)cc1C(=O)NCCC(=N)N
Standard InChI: InChI=1S/C72H81N27O12.3ClH/c1-91-31-43(19-49(91)64(103)79-13-10-58(73)74)85-70(109)55-25-46(34-97(55)7)88-67(106)52-22-40(28-94(52)4)82-61(100)37-16-38(62(101)83-41-23-53(95(5)29-41)68(107)89-47-26-56(98(8)35-47)71(110)86-44-20-50(92(2)32-44)65(104)80-14-11-59(75)76)18-39(17-37)63(102)84-42-24-54(96(6)30-42)69(108)90-48-27-57(99(9)36-48)72(111)87-45-21-51(93(3)33-45)66(105)81-15-12-60(77)78;;;/h16-36H,10-15H2,1-9H3,(H3,73,74)(H3,75,76)(H3,77,78)(H,79,103)(H,80,104)(H,81,105)(H,82,100)(H,83,101)(H,84,102)(H,85,109)(H,86,110)(H,87,111)(H,88,106)(H,89,107)(H,90,108);3*1H
Standard InChI Key: WVYRDPITVGJUSE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1516.62 | Molecular Weight (Monoisotopic): 1515.6558 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wang W, Lown JW.. (1992) Anti-HIV-I activity of linked lexitropsins., 35 (15): [PMID:1322989] [10.1021/jm00093a023] |
Source(1):